The next ELRIGfr meeting will take place in Monaco (November 27th and 28th) and our CDO, Grégory MAUBON, will organize a special session about the use of augmented and virtual reality in laboratories.

After a first “step” during last ELRIGfr event (Forum Labo Paris) where many possibilities were presented, it’s time now to look at real cases. Grégory, who is also president of RA’pro (Association for the Promotion of Augmented Reality), has chosen three uses with clear results :

  • Sopra Steria will present how to use 3D models in training and quality control with augmented reality
  • Agence dad and Molecular Devices will present how augmented reality could be used in laboratories for devices integration and training. Of course, we will talk about our use of augmented reality for our HAPIx installation !
  • MicroTechniX will present their use of virtual reality for ScanLab II, where you can test the equipment remotely and before the machine is built!

Of course, many other interesting things will be discussed during these two days, like personalized medicine and data management ! We will be happy to meet you in Monaco !

If you have any questions about integration of immersive technologies in biotechnologies, pharmaceutical industries (and even in other fields), feel free to contact Grégory !


2 Comments

Thanks ELRIGfr, Monaco event was great and it's always a pleasure to talk about augmented reality ! | HCS-pharma · December 11, 2017 at 2:49 pm

[…] as president of RA’pro (Association for the Promotion of Augmented Reality), to chair an augmented reality workshop with famous societies as Molecular Devices, Sopra Steria, agence dad and Microtechnix.  Many other […]

Digital workspace and the use of immersive technologies: we share our experiments! | HCS-pharma · March 19, 2018 at 3:13 pm

[…] platform thanks to partners Molecular Devices and agence dad. It was a great success! Then we organized a special session about the use of augmented and virtual reality in laboratories at ELRIG.fr Monaco to share with […]

Leave a Reply